Breaking News Instant updates and real-time market news.

GOTU

Gaotu Techedu

$2.44 /

+0.12 (+5.17%)

05:22
09/22/21
09/22
05:22
09/22/21
05:22

Gaotu Techedu reports Q2 EPS (83c), consensus (22c)

Reports Q2 revenue $345.73M, consensus $387.45M. Gross billings increased 12.2%. Paid course enrollments increased 4.1%. Larry Xiangdong Chen, the company's founder, chairman and CEO, commented, "In the second quarter of 2021, our revenue has reached a record high to 2.232 billion RMB. In order to support the equality of education, ever since May, we have successively collaborated with multiple non-profit organizations such as the China Charity's Aid Foundation for Children, the China Youth Development Foundation, the China Next Generation Education Foundation, and the Henan Normal University through cash donation or free course offerings, to aid the revitalization of rural area education and achieve the goal of equal access of education for everyone. At the same time, we have recently and rapidly adjusted the organizational structure of the group, to focus on professional education and STEAM education, and further exploring possibilities on digital products and vocational education. We say that 2014 is Gaotu's first attempt as a startup , and 2016 is our second start, then we can also say that 2021 is our third start. We should always keep the goal of education in mind, always firmly believe that education is a noble profession. It's undeniable that we have boundless faith in the bright future of the Chinese education industry."

  • 22

    Sep

GOTU Gaotu Techedu
$2.44 /

+0.12 (+5.17%)

07/27/21 Deutsche Bank
Gaotu Techedu price target lowered to $3 from $97 at Deutsche Bank
07/26/21
Gaotu Techedu downgraded to Sell from Underperform at CLSA
07/25/21 Goldman Sachs
Gaotu Techedu downgraded to Sell from Neutral at Goldman Sachs
07/23/21 JPMorgan
JPMorgan downgrades China education stock trio on 'unprecedented uncertainty'

TODAY'S FREE FLY STORIES

Initiation
Hertz reinstated with a Buy at Deutsche Bank » 18:21
12/05/21
12/05
18:21
12/05/21
18:21
HTZ

Hertz

$24.10 /

-0.14 (-0.58%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HTZ Hertz
$24.10 /

-0.14 (-0.58%)

HTZ Hertz
$24.10 /

-0.14 (-0.58%)

07/07/21 Deutsche Bank
Hertz price target raised to $18 from $2 at Deutsche Bank
06/16/21 Truist
TripAdvisor rolls out subscription product 'on schedule,' says Truist
  • 09
    Nov
HTZ Hertz
$24.10 /

-0.14 (-0.58%)

HTZ Hertz
$24.10 /

-0.14 (-0.58%)

Initiation
Rivian Automotive initiated with a Buy at Deutsche Bank » 18:20
12/05/21
12/05
18:20
12/05/21
18:20
RIVN

Rivian Automotive

$104.63 /

-6.19 (-5.59%)

Deutsche Bank initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RIVN Rivian Automotive
$104.63 /

-6.19 (-5.59%)

RIVN Rivian Automotive
$104.63 /

-6.19 (-5.59%)

12/01/21 Colliers
Ambarella price target raised to $245 from $135 at Colliers
12/01/21 Needham
Ambarella price target raised to $225 from $220 at Needham
12/01/21 KeyBanc
Ambarella price target raised to $230 from $185 at KeyBanc
  • 10
    Nov
RIVN Rivian Automotive
$104.63 /

-6.19 (-5.59%)

RIVN Rivian Automotive
$104.63 /

-6.19 (-5.59%)

RIVN Rivian Automotive
$104.63 /

-6.19 (-5.59%)

Periodicals
Vivendi open to discuss with Rome over state control on TIM network, Reuters says » 17:50
12/05/21
12/05
17:50
12/05/21
17:50
VIVHY

Vivendi

$12.68 /

+ (+0.00%)

, KKR

KKR

$73.67 /

-1.64 (-2.18%)

Telecom Italia's top…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIVHY Vivendi
$12.68 /

+ (+0.00%)

KKR KKR
$73.67 /

-1.64 (-2.18%)

VIVHY Vivendi
$12.68 /

+ (+0.00%)

11/30/21 JPMorgan
Vivendi price target raised to EUR 14 from EUR 12.70 at JPMorgan
11/16/21 BofA
BofA downgrades Warner Music to Underperform on limited near-term catalysts
10/25/21 JPMorgan
Vivendi price target lowered to EUR 12.70 from EUR 13 at JPMorgan
10/22/21 Credit Suisse
Vivendi price target raised to EUR 13.70 from EUR 13.20 at Credit Suisse
KKR KKR
$73.67 /

-1.64 (-2.18%)

11/19/21 Citi
KKR resumed with a Buy at Citi
11/16/21 Credit Suisse
CyrusOne price target raised to $90.50 from $83 at Credit Suisse
11/15/21 Stifel
CyrusOne acquisition by KKR, GIP 'makes sense,' says Stifel
11/04/21 Argus
KKR price target raised to $94 from $72 at Argus
KKR KKR
$73.67 /

-1.64 (-2.18%)

VIVHY Vivendi
$12.68 /

+ (+0.00%)

KKR KKR
$73.67 /

-1.64 (-2.18%)

VIVHY Vivendi
$12.68 /

+ (+0.00%)

KKR KKR
$73.67 /

-1.64 (-2.18%)

KKR KKR
$73.67 /

-1.64 (-2.18%)

Hot Stocks
J&J COVID-19 booster shows increase in antibody, T-cell responses » 17:12
12/05/21
12/05
17:12
12/05/21
17:12
JNJ

Johnson & Johnson

$159.37 /

+2.25 (+1.43%)

Johnson & Johnson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

JNJ Johnson & Johnson
$159.37 /

+2.25 (+1.43%)

On The Fly
Box Office Battle: 'Encanto' wins post-Thanksgiving weekend with $12.7M » 15:49
12/05/21
12/05
15:49
12/05/21
15:49
T

AT&T

$23.47 /

+0.425 (+1.84%)

, CMCSA

Comcast

$51.84 /

+0.34 (+0.66%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, SONY

Sony

$120.04 /

-0.13 (-0.11%)

, LGF.A

Lionsgate

$15.07 /

+0.07 (+0.47%)

, LGF.B

Lionsgate

$13.84 /

+0.04 (+0.29%)

, DIS

Disney

$146.22 /

-0.99 (-0.67%)

, VIACA

ViacomCBS

$34.21 /

+1.71 (+5.26%)

, VIAC

ViacomCBS

$31.05 /

+1.48 (+5.01%)

"Box Office Battle" is…

ShowHide Related Items >><<
VIACA ViacomCBS
$34.21 /

+1.71 (+5.26%)

T AT&T
$23.47 /

+0.425 (+1.84%)

SONY Sony
$120.04 /

-0.13 (-0.11%)

LGF.B Lionsgate
$13.84 /

+0.04 (+0.29%)

LGF.A Lionsgate
$15.07 /

+0.07 (+0.47%)

DIS Disney
$146.22 /

-0.99 (-0.67%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$51.84 /

+0.34 (+0.66%)

T AT&T
$23.47 /

+0.425 (+1.84%)

11/11/21 Lake Street
Smith Micro target raised to $9 at Lake Street after 'major' T-Mobile milestone
10/19/21 Citi
AT&T price target lowered to $30 from $32 at Citi
10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 KeyBanc
AT&T upgraded to Sector Weight from Underweight at KeyBanc
CMCSA Comcast
$51.84 /

+0.34 (+0.66%)

11/22/21 Loop Capital
Comcast price target lowered to $67 from $71 at Loop Capital
11/01/21 Citi
Comcast price target lowered to $60 from $65 at Citi
11/01/21 Barclays
Comcast price target lowered to $60 from $65 at Barclays
10/29/21 Pivotal Research
Comcast price target lowered to $72 from $75 at Pivotal Research
CMCSK Comcast
$58.00 /

+ (+0.00%)

02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
SONY Sony
$120.04 /

-0.13 (-0.11%)

09/27/21 Cowen
Sony initiated with an Outperform at Cowen
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
07/27/21 Morgan Stanley
Sony upgraded to Overweight at Morgan Stanley on animation business growth
07/27/21 Morgan Stanley
Sony upgraded to Overweight from Equal Weight at Morgan Stanley
LGF.A Lionsgate
$15.07 /

+0.07 (+0.47%)

10/13/21
Fly Intel: Top five analyst initiations
10/13/21 Benchmark
Lionsgate initiated with a Buy at Benchmark
07/22/21 Deutsche Bank
Lionsgate downgraded to Hold from Buy at Deutsche Bank
06/04/21 Barrington
Lionsgate price target raised to $27 from $16 at Barrington
LGF.B Lionsgate
$13.84 /

+0.04 (+0.29%)

06/01/21 Cowen
Lionsgate price target raised to $23 from $20 at Cowen
05/28/21 RBC Capital
Lionsgate price target raised to $17 from $13 at RBC Capital
05/26/21 Truist
Amazon's MGM deal 'a very modest negative' for Netflix/Disney, says Truist
DIS Disney
$146.22 /

-0.99 (-0.67%)

11/29/21 Loop Capital
Disney price target lowered to $190 from $205 at Loop Capital
11/22/21 Wells Fargo
Disney price target lowered to $196 from $203 at Wells Fargo
11/16/21 Citi
Disney price target lowered to $210 from $230 at Citi
11/15/21 Roth Capital
DraftKings price target lowered to $34 from $39 at Roth Capital
VIACA ViacomCBS
$34.21 /

+1.71 (+5.26%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
VIAC ViacomCBS
$31.05 /

+1.48 (+5.01%)

10/15/21 Deutsche Bank
ViacomCBS price target lowered to $44 from $45 at Deutsche Bank
08/18/21
Fly Intel: Top five analyst upgrades
08/18/21 Wells Fargo
ViacomCBS upgraded to Overweight from Equal Weight at Wells Fargo
08/06/21
Fly Intel: Top five analyst upgrades
VIACA ViacomCBS
$34.21 /

+1.71 (+5.26%)

T AT&T
$23.47 /

+0.425 (+1.84%)

SONY Sony
$120.04 /

-0.13 (-0.11%)

LGF.A Lionsgate
$15.07 /

+0.07 (+0.47%)

DIS Disney
$146.22 /

-0.99 (-0.67%)

CMCSA Comcast
$51.84 /

+0.34 (+0.66%)

  • 06
    Apr
  • 29
    Mar
  • 24
    Mar
VIACA ViacomCBS
$34.21 /

+1.71 (+5.26%)

T AT&T
$23.47 /

+0.425 (+1.84%)

SONY Sony
$120.04 /

-0.13 (-0.11%)

LGF.A Lionsgate
$15.07 /

+0.07 (+0.47%)

DIS Disney
$146.22 /

-0.99 (-0.67%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$51.84 /

+0.34 (+0.66%)

VIACA ViacomCBS
$34.21 /

+1.71 (+5.26%)

T AT&T
$23.47 /

+0.425 (+1.84%)

SONY Sony
$120.04 /

-0.13 (-0.11%)

DIS Disney
$146.22 /

-0.99 (-0.67%)

CMCSA Comcast
$51.84 /

+0.34 (+0.66%)

VIAC ViacomCBS
$31.05 /

+1.48 (+5.01%)

T AT&T
$23.47 /

+0.425 (+1.84%)

DIS Disney
$146.22 /

-0.99 (-0.67%)

CMCSA Comcast
$51.84 /

+0.34 (+0.66%)

Periodicals
Spotify removes some comedians' work from streaming service, WSJ says » 15:19
12/05/21
12/05
15:19
12/05/21
15:19
SPOT

Spotify

$228.71 /

+0.18 (+0.08%)

, SIRI

Sirius XM

$6.22 /

-0.03 (-0.48%)

, GOOG

Alphabet

$2,850.58 /

-25.935 (-0.90%)

, GOOGL

Alphabet Class A

$2,842.56 /

-16.48 (-0.58%)

Spotify (SPOT) has…

Spotify (SPOT) has removed the work of hundreds of comedians, including John Mulaney, Jim Gaffigan and Kevin Hart, amid a new fight over royalty payments, The Wall Street Journal's Anne Steele reports. Tiffany Haddish, Mike Birbiglia and a host of other popular acts have joined a group of entertainers trying to get paid a royalty on a copyright for jokes they wrote when they are played on radio and digital service providers like Spotify, SiriusXM (SIRI), Pandora and YouTube (GOOG), the author notes. The comedians' effort is largely led by Spoken Giants. Spotify took the content down after reaching an impasse with Spoken Giants, the publication adds. Reference Link

ShowHide Related Items >><<
SPOT Spotify
$228.71 /

+0.18 (+0.08%)

SIRI Sirius XM
$6.22 /

-0.03 (-0.48%)

GOOGL Alphabet Class A
$2,842.56 /

-16.48 (-0.58%)

GOOG Alphabet
$2,850.58 /

-25.935 (-0.90%)

SPOT Spotify
$228.71 /

+0.18 (+0.08%)

11/24/21
Fly Intel: Top five analyst initiations
11/24/21 Benchmark
Spotify initiated with a Buy at Benchmark
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/16/21 BofA
BofA downgrades Warner Music to Underperform on limited near-term catalysts
SIRI Sirius XM
$6.22 /

-0.03 (-0.48%)

11/19/21
Fly Intel: Top five analyst downgrades
11/19/21 Barclays
Sirius XM downgraded to Underweight om slowing growth at Barclays
11/19/21 Barclays
Sirius XM downgraded to Underweight from Equal Weight at Barclays
10/19/21 Pivotal Research
Sirius XM price target lowered to $8 from $8.25 at Pivotal Research
GOOG Alphabet
$2,850.58 /

-25.935 (-0.90%)

12/03/21 Tigress Financial
Alphabet price target raised to $3,540 from $3,185 at Tigress Financial
12/02/21 BofA
C3.ai downgraded to Underperform at BofA after 'disappointing' Q2 report
11/02/21 Morgan Stanley
Alphabet price target raised to $3,200 from $3,000 at Morgan Stanley
GOOGL Alphabet Class A
$2,842.56 /

-16.48 (-0.58%)

12/02/21 UBS
Alphabet assumed with a Buy at UBS
SPOT Spotify
$228.71 /

+0.18 (+0.08%)

SIRI Sirius XM
$6.22 /

-0.03 (-0.48%)

GOOG Alphabet
$2,850.58 /

-25.935 (-0.90%)

SPOT Spotify
$228.71 /

+0.18 (+0.08%)

GOOG Alphabet
$2,850.58 /

-25.935 (-0.90%)

SPOT Spotify
$228.71 /

+0.18 (+0.08%)

SIRI Sirius XM
$6.22 /

-0.03 (-0.48%)

GOOG Alphabet
$2,850.58 /

-25.935 (-0.90%)

SPOT Spotify
$228.71 /

+0.18 (+0.08%)

SIRI Sirius XM
$6.22 /

-0.03 (-0.48%)

GOOGL Alphabet Class A
$2,842.56 /

-16.48 (-0.58%)

Periodicals
Deutsche Post CEO favorite for Deutsche Telekom chairman, Bloomberg says » 15:15
12/05/21
12/05
15:15
12/05/21
15:15
DPSGY

Deutsche Post

$58.77 /

-0.16 (-0.27%)

, DTEGY

Deutsche Telekom

$17.61 /

-0.16 (-0.90%)

Deutsche Post (DPSGY)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DTEGY Deutsche Telekom
$17.61 /

-0.16 (-0.90%)

DPSGY Deutsche Post
$58.77 /

-0.16 (-0.27%)

11/05/21 JPMorgan
Deutsche Post price target lowered to EUR 72 from EUR 73.44 at JPMorgan
10/07/21 JPMorgan
Deutsche Post price target lowered to EUR from EUR 76.10 at JPMorgan
09/29/21 Goldman Sachs
Deutsche Post downgraded to Buy from Conviction Buy at Goldman Sachs
09/22/21 Morgan Stanley
Deutsche Post resumed with an Overweight at Morgan Stanley
DTEGY Deutsche Telekom
$17.61 /

-0.16 (-0.90%)

12/01/21 JPMorgan
Deutsche Telekom price target lowered to EUR 26.50 from EUR 28 at JPMorgan
11/15/21 UBS
Deutsche Telekom price target raised to EUR 24.50 from EUR 24.20 at UBS
10/18/21 Deutsche Bank
Deutsche Telekom named short-term investment idea at Deutsche Bank
10/14/21 JPMorgan
Deutsche Telekom price target lowered to EUR 28 from EUR 29 at JPMorgan
DPSGY Deutsche Post
$58.77 /

-0.16 (-0.27%)

DTEGY Deutsche Telekom
$17.61 /

-0.16 (-0.90%)

DTEGY Deutsche Telekom
$17.61 /

-0.16 (-0.90%)

DPSGY Deutsche Post
$58.77 /

-0.16 (-0.27%)

Periodicals
Chinese auto part maker says products involved in Tesla recall, Bloomberg reports » 15:09
12/05/21
12/05
15:09
12/05/21
15:09
TSLA

Tesla

$1,014.65 /

-69.85 (-6.44%)

Ningbo Tuopu Group said…

Ningbo Tuopu Group said it was the supplier of parts that prompted recent recalls of Tesla Model Y cars in China and the U.S., according to Bloomberg. Some front- and rear-suspension knuckles weren't completely immersed in a liquid during the heating process, the Chinese auto-parts maker said in an exchange filing on Sunday. The potential of any knuckle being defective might be as high as 1%, it said. Reference Link

ShowHide Related Items >><<
TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

11/30/21 GLJ Research
Tesla 'leak' an attempt to lower, then beat, Q4 expectations, says GLJ Research
11/24/21 Morgan Stanley
Morgan Stanley stays Underweight Ford, admits to being wrong after near-double
11/19/21 Morgan Stanley
Apple Car would be 'ultimate EV bear case,' says Morgan Stanley
11/19/21 Wedbush
Tesla price target raised to $1,400 from $1,100 at Wedbush
TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

TSLA Tesla
$1,014.65 /

-69.85 (-6.44%)

Periodicals
iPhone 13 rebates fail to deliver for some buyers, Bloomberg reports » 14:59
12/05/21
12/05
14:59
12/05/21
14:59
AAPL

Apple

$161.85 /

-1.95 (-1.19%)

Some customers are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$161.85 /

-1.95 (-1.19%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

12/03/21 JPMorgan
JPMorgan does not think Apple cut Q4 iPhone orders despite report
12/02/21 Wedbush
Wedbush sees $3 trillion market cap for Apple in 2022, ups price target
12/01/21 UBS
Apple wait times showing 'modest' easing, says UBS
11/26/21 Wedbush
Wedbush sees Apple on pace to sell over 10M iPhones over Black Friday weekend
AAPL Apple
$161.85 /

-1.95 (-1.19%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

AAPL Apple
$161.85 /

-1.95 (-1.19%)

Hot Stocks
Trump Media, Digital World Acquisition announce $1B PIPE investment » 14:50
12/05/21
12/05
14:50
12/05/21
14:50
DWAC

Digital World Acquisition

$44.78 /

-2.16 (-4.60%)

Trump Media &…

Trump Media & Technology Group Corp. and Digital World Acquisition Corp. announced that the latter has entered into subscription agreements for $1 billion in committed capital to be received upon consummation of their business combination from a diverse group of institutional investors. President Donald Trump, Chairman of TMTG, stated, "$1 billion sends an important message to Big Tech that censorship and political discrimination must end. America is ready for TRUTH Social, a platform that will not discriminate on the basis of political ideology. As our balance sheet expands, TMTG will be in a stronger position to fight back against the tyranny of Big Tech." Together, the transaction will provide estimated proceeds of approximately $1.25 billion - after deducting estimated deal expenses -, assuming full delivery of the amount of cash held in trust by DWAC, to be used to fund operations of the combined entity. The per-share conversion price of the fully committed convertible preferred stock PIPE transaction represents a 20% discount to DWAC's volume-weighted average closing price for the five trading days prior to and including December 1, 2021, subject to downward adjustment. If the VWAP of the combined entity for the 10 trading days after the closing of the business combination is at or above $56, no downward adjustment will occur. If the Closing VWAP is below $56, then the conversion price shall be adjusted to the greater of a 40% discount to the Closing VWAP and the floor price of $10.00. The PIPE financing is subject to customary closing conditions, including stockholder and regulatory approval, and is expected to close upon or shortly after the consummation of the business combination.

ShowHide Related Items >><<
DWAC Digital World Acquisition
$44.78 /

-2.16 (-4.60%)

DWAC Digital World Acquisition
$44.78 /

-2.16 (-4.60%)

DWAC Digital World Acquisition
$44.78 /

-2.16 (-4.60%)

DWAC Digital World Acquisition
$44.78 /

-2.16 (-4.60%)

On The Fly
Week in SPAC News: BuzzFeed hit with wave of withdrawals ahead of merger closing » 07:29
12/05/21
12/05
07:29
12/05/21
07:29
ENFA

890 5th Avenue Partners

$9.54 /

-0.33 (-3.34%)

, BZFD

BuzzFeed

/

+

, APSG

Apollo Strategic Growth Capital

$9.92 /

+0.09 (+0.92%)

, GBTG

Global Business Travel Group

/

+

, ZM

Zoom Video

$183.85 /

-7.4 (-3.87%)

, SABR

Sabre

$8.10 /

-0.265 (-3.17%)

, AXP

American Express

$155.91 /

-0.9 (-0.57%)

, CFVI

CF Acquisition Corp. VI

$11.90 /

+1.37 (+13.01%)

, DWAC

Digital World Acquisition

$44.78 /

-2.16 (-4.60%)

, BOAS

BOA Acquisition

$9.85 /

+0.02 (+0.20%)

, FST

Fast Acquisition

$10.20 /

+0.1 (+0.99%)

, GRAB

Grab

$8.93 /

+0.21 (+2.41%)

, AGC

Altimeter Growth

$11.11 /

+ (+0.00%)

, SEAH

Sports Entertainment Acquisition

$10.44 /

+0.04 (+0.38%)

, SGHC

Super Group

/

+

, TREB

Trebia Acquisition

$9.94 /

+0.01 (+0.10%)

, SST

System1

/

+

, BIOS

BioPlus Acquisition

/

+

, BPAC

Bullpen Parlay Acquisition

/

+

, BOCN

Blue Ocean Acquisition

/

+

, STET

ST Energy Transition I

/

+

, GEEX

Games & Esports Experience Acquisition

/

+

, ROCA

ROC Energy Acquisition

/

+

, UTAA

UTA Acquisition

/

+

, CMCA

Capitalworks Emerging Markets Acquisition

/

+

, TLGY

TLGY Acquisition

/

+

, CNGL

Canna-Global Acquisition

/

+

In SPAC news this week,…

ShowHide Related Items >><<
ZM Zoom Video
$183.85 /

-7.4 (-3.87%)

TREB Trebia Acquisition
$9.94 /

+0.01 (+0.10%)

SGHC Super Group
/

+

SEAH Sports Entertainment Acquisition
$10.44 /

+0.04 (+0.38%)

SABR Sabre
$8.10 /

-0.265 (-3.17%)

GRAB Grab
$8.93 /

+0.21 (+2.41%)

FST Fast Acquisition
$10.20 /

+0.1 (+0.99%)

ENFA 890 5th Avenue Partners
$9.54 /

-0.33 (-3.34%)

DWAC Digital World Acquisition
$44.78 /

-2.16 (-4.60%)

CFVI CF Acquisition Corp. VI
$11.90 /

+1.37 (+13.01%)

BOAS BOA Acquisition
$9.85 /

+0.02 (+0.20%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

APSG Apollo Strategic Growth Capital
$9.92 /

+0.09 (+0.92%)

AGC Altimeter Growth
$11.11 /

+ (+0.00%)

ENFA 890 5th Avenue Partners
$9.54 /

-0.33 (-3.34%)

BZFD BuzzFeed
/

+

APSG Apollo Strategic Growth Capital
$9.92 /

+0.09 (+0.92%)

GBTG Global Business Travel Group
/

+

ZM Zoom Video
$183.85 /

-7.4 (-3.87%)

11/30/21 Daiwa
Zoom Video upgraded to Underperform from Sell at Daiwa
11/23/21
Fly Intel: Top five analyst downgrades
11/23/21 BofA
Zoom Video downgraded to Neutral from Buy at BofA
11/23/21 Wells Fargo
Zoom Video price target lowered to $245 from $275 at Wells Fargo
SABR Sabre
$8.10 /

-0.265 (-3.17%)

05/05/21 Mizuho
Sabre price target lowered to $13 from $15 at Mizuho
04/16/21 Mizuho
Sabre price target raised to $15 from $13 at Mizuho
03/29/21 Mizuho
Sabre price target raised to $13 from $11 at Mizuho
03/16/21 Morgan Stanley
Sabre downgraded to Equal Weight at Morgan Stanley following over 50% rally
AXP American Express
$155.91 /

-0.9 (-0.57%)

10/29/21 Citi
Citi upgrades Synchrony to Buy on higher loan growth estiamtes
10/25/21 BMO Capital
American Express price target raised to $151 from $147 at BMO Capital
10/25/21 Deutsche Bank
American Express price target raised to $200 from $190 at Deutsche Bank
10/25/21 Stephens
American Express price target raised to $190 from $180 at Stephens
CFVI CF Acquisition Corp. VI
$11.90 /

+1.37 (+13.01%)

DWAC Digital World Acquisition
$44.78 /

-2.16 (-4.60%)

BOAS BOA Acquisition
$9.85 /

+0.02 (+0.20%)

FST Fast Acquisition
$10.20 /

+0.1 (+0.99%)

GRAB Grab
$8.93 /

+0.21 (+2.41%)

10/01/21 New Street
Grab partner Altimeter Growth initiated with a Buy at New Street
AGC Altimeter Growth
$11.11 /

+ (+0.00%)

SEAH Sports Entertainment Acquisition
$10.44 /

+0.04 (+0.38%)

11/30/21 Benchmark
Sports Entertainment Acquisition initiated with a Buy at Benchmark
SGHC Super Group
/

+

TREB Trebia Acquisition
$9.94 /

+0.01 (+0.10%)

11/29/21 DA Davidson
Trebia Acquisition initiated with a Buy at DA Davidson
11/18/21 Benchmark
Trebia Acquisition Corp. initiated with a Buy at Benchmark
SST System1
/

+

BIOS BioPlus Acquisition
/

+

BPAC Bullpen Parlay Acquisition
/

+

BOCN Blue Ocean Acquisition
/

+

STET ST Energy Transition I
/

+

GEEX Games & Esports Experience Acquisition
/

+

ROCA ROC Energy Acquisition
/

+

UTAA UTA Acquisition
/

+

CMCA Capitalworks Emerging Markets Acquisition
/

+

TLGY TLGY Acquisition
/

+

CNGL Canna-Global Acquisition
/

+

ZM Zoom Video
$183.85 /

-7.4 (-3.87%)

SABR Sabre
$8.10 /

-0.265 (-3.17%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

  • 13
    Jan
ZM Zoom Video
$183.85 /

-7.4 (-3.87%)

ENFA 890 5th Avenue Partners
$9.54 /

-0.33 (-3.34%)

DWAC Digital World Acquisition
$44.78 /

-2.16 (-4.60%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

AGC Altimeter Growth
$11.11 /

+ (+0.00%)

ZM Zoom Video
$183.85 /

-7.4 (-3.87%)

GRAB Grab
$8.93 /

+0.21 (+2.41%)

FST Fast Acquisition
$10.20 /

+0.1 (+0.99%)

ENFA 890 5th Avenue Partners
$9.54 /

-0.33 (-3.34%)

DWAC Digital World Acquisition
$44.78 /

-2.16 (-4.60%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

APSG Apollo Strategic Growth Capital
$9.92 /

+0.09 (+0.92%)

ZM Zoom Video
$183.85 /

-7.4 (-3.87%)

SEAH Sports Entertainment Acquisition
$10.44 /

+0.04 (+0.38%)

SABR Sabre
$8.10 /

-0.265 (-3.17%)

GRAB Grab
$8.93 /

+0.21 (+2.41%)

DWAC Digital World Acquisition
$44.78 /

-2.16 (-4.60%)

AXP American Express
$155.91 /

-0.9 (-0.57%)

APSG Apollo Strategic Growth Capital
$9.92 /

+0.09 (+0.92%)

AGC Altimeter Growth
$11.11 /

+ (+0.00%)

Conference/Events
Southwest to host virtual investor day » 17:37
12/04/21
12/04
17:37
12/04/21
17:37
LUV

Southwest

$44.28 /

-1.07 (-2.36%)

Virtual Investor Day to…

Virtual Investor Day to be held on December 8 at 12 pm. Webcast Link

ShowHide Related Items >><<
LUV Southwest
$44.28 /

-1.07 (-2.36%)

LUV Southwest
$44.28 /

-1.07 (-2.36%)

12/01/21 MKM Partners
Southwest price target lowered to $56 from $61 at MKM Partners
11/19/21
Fly Intel: Top five analyst upgrades
11/19/21 Wolfe Research
Southwest upgraded to Outperform from Peer Perform at Wolfe Research
11/16/21
Fly Intel: Top five analyst downgrades
LUV Southwest
$44.28 /

-1.07 (-2.36%)

LUV Southwest
$44.28 /

-1.07 (-2.36%)

LUV Southwest
$44.28 /

-1.07 (-2.36%)

LUV Southwest
$44.28 /

-1.07 (-2.36%)

Conference/Events
Edwards Lifesciences to host investor meeting » 17:32
12/04/21
12/04
17:32
12/04/21
17:32
EW

Edwards Lifesciences

$108.54 /

-1.23 (-1.12%)

Investor meeting to be…

Investor meeting to be held in Irvine, CA on December 8 at 11:30 am. Webcast Link

ShowHide Related Items >><<
EW Edwards Lifesciences
$108.54 /

-1.23 (-1.12%)

EW Edwards Lifesciences
$108.54 /

-1.23 (-1.12%)

11/30/21 Piper Sandler
Edwards Lifesciences positioned as 'beat-and-raise story,' says Piper Sandler
10/29/21 Jefferies
Edwards Lifesciences price target raised to $135 from $130 at Jefferies
10/28/21 Wells Fargo
Edwards Lifesciences price target raised to $126 from $115 at Wells Fargo
10/28/21 Citi
Edwards Lifesciences price target raised to $120 from $113 at Citi
EW Edwards Lifesciences
$108.54 /

-1.23 (-1.12%)

EW Edwards Lifesciences
$108.54 /

-1.23 (-1.12%)

EW Edwards Lifesciences
$108.54 /

-1.23 (-1.12%)

Conference/Events
Karyopharm to host virtual investor day » 17:29
12/04/21
12/04
17:29
12/04/21
17:29
KPTI

Karyopharm

$6.73 /

-0.53 (-7.30%)

Virtual Investor Day to…

Virtual Investor Day to be held on December 8 at 10 am. Webcast Link

ShowHide Related Items >><<
KPTI Karyopharm
$6.73 /

-0.53 (-7.30%)

KPTI Karyopharm
$6.73 /

-0.53 (-7.30%)

11/19/21 Morgan Stanley
Karyopharm assumed at Equal Weight from Overweight at Morgan Stanley
08/06/21 JPMorgan
JPMorgan double downgrades Karyopharm on Xpovio weakness
08/06/21 Baird
Karyopharm price target lowered to $17 from $30 at Baird
08/06/21 SVB Leerink
Karyopharm downgraded to Market Perform from Outperform at SVB Leerink
KPTI Karyopharm
$6.73 /

-0.53 (-7.30%)

KPTI Karyopharm
$6.73 /

-0.53 (-7.30%)

Conference/Events
Newmarkto hold virtual investor event » 17:20
12/04/21
12/04
17:20
12/04/21
17:20
NMRK

Newmark

$15.96 /

-0.16 (-0.99%)

Analyst and Investor…

Analyst and Investor Event to be held on December 7 at 10 am. Webcast Link

ShowHide Related Items >><<
NMRK Newmark
$15.96 /

-0.16 (-0.99%)

NMRK Newmark
$15.96 /

-0.16 (-0.99%)

06/14/21 Wolfe Research
Newmark initiated with an Outperform at Wolfe Research
02/25/21 BofA
Newmark double-upgraded to Buy from Underperform at BofA
02/19/21 Piper Sandler
Newmark upgraded to Overweight from Neutral at Piper Sandler
01/25/21 Goldman Sachs
Newmark initiated with a Buy at Goldman Sachs
NMRK Newmark
$15.96 /

-0.16 (-0.99%)

Conference/Events
Meritor to hold a virtual event » 17:12
12/04/21
12/04
17:12
12/04/21
17:12
MTOR

Meritor

$26.21 /

+0.35 (+1.35%)

Virtual Strategy Day 2021…

Virtual Strategy Day 2021 to be held on December 7 at 10 am. Webcast Link

ShowHide Related Items >><<
MTOR Meritor
$26.21 /

+0.35 (+1.35%)

MTOR Meritor
$26.21 /

+0.35 (+1.35%)

11/18/21 RBC Capital
Meritor price target raised to $32 from $29 at RBC Capital
11/18/21 Barclays
Meritor price target raised to $28 from $27 at Barclays
07/07/21 Barclays
Meritor price target lowered to $27 from $30 at Barclays
07/01/21
Fly Intel: Top five analyst upgrades
MTOR Meritor
$26.21 /

+0.35 (+1.35%)

MTOR Meritor
$26.21 /

+0.35 (+1.35%)

Conference/Events
LivaNova to host virtual investor day » 16:16
12/04/21
12/04
16:16
12/04/21
16:16
LIVN

LivaNova

$80.18 /

-2.07 (-2.52%)

Virtual Investor Day to…

Virtual Investor Day to be held on December 7 at 9 am. Webcast Link

ShowHide Related Items >><<
LIVN LivaNova
$80.18 /

-2.07 (-2.52%)

LIVN LivaNova
$80.18 /

-2.07 (-2.52%)

12/03/21
Fly Intel: Top five analyst initiations
12/03/21 Goldman Sachs
LivaNova initiated with a Buy at Goldman Sachs
11/15/21 Piper Sandler
LivaNova financing likely after court ruling, says Piper Sandler
11/03/21 Piper Sandler
LivaNova price target raised to $105 from $100 at Piper Sandler
LIVN LivaNova
$80.18 /

-2.07 (-2.52%)

  • 04
    Aug
LIVN LivaNova
$80.18 /

-2.07 (-2.52%)

Conference/Events
Eastman Chemical to hold a virtual event » 10:03
12/04/21
12/04
10:03
12/04/21
10:03
EMN

Eastman Chemical

$107.79 /

+2.69 (+2.56%)

Virtual Eastman…

Virtual Eastman Innovation Day 2021 to be held on December 7 at 8:30 am.Webcast Link

ShowHide Related Items >><<
EMN Eastman Chemical
$107.79 /

+2.69 (+2.56%)

EMN Eastman Chemical
$107.79 /

+2.69 (+2.56%)

11/12/21 Piper Sandler
Eastman Chemical initiated with a Neutral at Piper Sandler
11/01/21 Deutsche Bank
Eastman Chemical earnings selloff overdone, says Deutsche Bank
11/01/21 JPMorgan
Eastman Chemical downgraded to Neutral from Overweight at JPMorgan
08/05/21
Fly Intel: Top five analyst upgrades
EMN Eastman Chemical
$107.79 /

+2.69 (+2.56%)

EMN Eastman Chemical
$107.79 /

+2.69 (+2.56%)

Periodicals
Nintendo 'an overlooked metaverse play,' time to buy stock, Barron's says » 09:43
12/04/21
12/04
09:43
12/04/21
09:43
NTDOY

Nintendo

$55.80 /

-1.2 (-2.11%)

, RBLX

Roblox

$113.78 /

-3.22 (-2.75%)

, NVDA

Nvidia

$307.18 /

-13.7 (-4.27%)

Nintendo (NTDOY) is still…

Nintendo (NTDOY) is still making games that are adored by its fans. But investors have spent much of the year looking for companies making big promises about the "metaverse"-the idea of virtual worlds that enable social interaction and commerce, Connor Smith writes in this week's edition of Barron's. That has powered stocks like Roblox (RBLX) and Nvidia (NVDA) to huge gains this year. But any future metaverse success isn't in Nintendo's numbers, and new games could create renewed momentum for the Switch, helping Nintendo exceed Wall Street's undemanding forecasts, the author notes. Reference Link

ShowHide Related Items >><<
RBLX Roblox
$113.78 /

-3.22 (-2.75%)

NVDA Nvidia
$307.18 /

-13.7 (-4.27%)

NTDOY Nintendo
$55.80 /

-1.2 (-2.11%)

NTDOY Nintendo
$55.80 /

-1.2 (-2.11%)

11/05/21 Macquarie
Nintendo downgraded to Neutral from Outperform at Macquarie
11/05/21 Macquarie
Nintendo downgraded to Neutral from Outperform at Macquarie
10/28/21 Wedbush
Nintendo upgraded to Outperform from Neutral at Wedbush
10/01/21 DZ Bank
Nintendo downgraded to Hold from Buy at DZ Bank
RBLX Roblox
$113.78 /

-3.22 (-2.75%)

11/18/21 Atlantic Equities
Roblox price target raised to $125 from $110 at Atlantic Equities
11/18/21 Stifel
Roblox price target raised to $134 from $121 at Stifel
11/17/21 Morgan Stanley
Roblox price target raised to $150 from $88 at Morgan Stanley
11/17/21 Morgan Stanley
Morgan Stanley says Roblox analyst day highlighted early leadership in metaverse
NVDA Nvidia
$307.18 /

-13.7 (-4.27%)

12/03/21 Citi
Citi now sees 5% chance of Nvidia acquiring Arm
12/02/21 Tigress Financial
Nvidia price target raised to $400 from $230 at Tigress Financial
11/26/21
Nvidia upgraded to Buy from Hold at First Shanghai
11/18/21 Raymond James
Nvidia price target raised to $365 from $225 at Raymond James
RBLX Roblox
$113.78 /

-3.22 (-2.75%)

NVDA Nvidia
$307.18 /

-13.7 (-4.27%)

NTDOY Nintendo
$55.80 /

-1.2 (-2.11%)

RBLX Roblox
$113.78 /

-3.22 (-2.75%)

NVDA Nvidia
$307.18 /

-13.7 (-4.27%)

NTDOY Nintendo
$55.80 /

-1.2 (-2.11%)

RBLX Roblox
$113.78 /

-3.22 (-2.75%)

NVDA Nvidia
$307.18 /

-13.7 (-4.27%)

NTDOY Nintendo
$55.80 /

-1.2 (-2.11%)

RBLX Roblox
$113.78 /

-3.22 (-2.75%)

NVDA Nvidia
$307.18 /

-13.7 (-4.27%)

Periodicals
Deere stock could benefit from sustained inflation, Barron's says » 09:38
12/04/21
12/04
09:38
12/04/21
09:38
DE

Deere

$349.13 /

-1.34 (-0.38%)

Inflation will be part of…

Inflation will be part of our lives longer than most imagined and that could be good news for industrial stocks, Jacob Sonenshine writes in this week's edition of Barron's. The recent selloff in industrial stocks has left some names looking particularly cheap. Deere, for instance, trades at 14.7 times its next 12 months' expected free cash flow per share, below its five-year average of 20.7 times, the authors notes. That's despite the fact that the $107 billion agriculture and construction equipment manufacturer is expected to grow free cash flow in the high teens over the next two years, he adds. Reference Link

ShowHide Related Items >><<
DE Deere
$349.13 /

-1.34 (-0.38%)

DE Deere
$349.13 /

-1.34 (-0.38%)

11/29/21 Stifel
Deere price target raised to $445 from $430 at Stifel
11/29/21 Evercore ISI
Deere price target raised to $415 from $354 at Evercore ISI
11/29/21 Deutsche Bank
Deere price target raised to $398 from $375 at Deutsche Bank
11/26/21 Morgan Stanley
Deere price target raised to $485 from $442 at Morgan Stanley
DE Deere
$349.13 /

-1.34 (-0.38%)

DE Deere
$349.13 /

-1.34 (-0.38%)

DE Deere
$349.13 /

-1.34 (-0.38%)

DE Deere
$349.13 /

-1.34 (-0.38%)

Periodicals
Bristol stock too cheap, could be ready to rally, Barron's says » 09:35
12/04/21
12/04
09:35
12/04/21
09:35
BMY

Bristol-Myers

$56.30 /

+0.89 (+1.61%)

A healthcare crisis…

A healthcare crisis should have been good for biopharma stocks. Instead, it's been anything but. That may be about to change, Ben Levisohn writes in this week's edition of Barron's. Few pharma companies have been hit as hard as Bristol-Myers, with the stock dropping 11% so far this year amid concerns that it will lose exclusivity on drugs like multiple-myeloma treatment Revlimid in 2022, and cancer treatment Opdivo and blood-clot preventer Eliquis later this decade, the authors notes. But if pharma is cheap, then Bristol, at just seven times 2022 earnings, looks like a bargain-especially if those concerns are overblown, he contends. Reference Link

ShowHide Related Items >><<
BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

11/23/21 Societe Generale
Societe Generale upgrades AbbVie to Buy on better than anticipated execution
11/18/21 BMO Capital
Bristol-Myers initiated with an Outperform at BMO Capital
11/15/21 Evercore ISI
Ventyx Biosciences initiated with an Outperform at Evercore ISI
11/15/21 Jefferies
Jefferies starts Ventyx at Buy based on blockbuster potential
BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

BMY Bristol-Myers
$56.30 /

+0.89 (+1.61%)

Periodicals
Twitter finally getting a full-time CEO, Barron's says » 09:29
12/04/21
12/04
09:29
12/04/21
09:29
TWTR

Twitter

$42.07 /

-0.54 (-1.27%)

Wall Street folks used to…

Wall Street folks used to say Twitter stock would jump when co-founder and CEO Jack Dorsey finally surrendered the reins to a chief executive solely focused on the social-media company, and yet the stock is down about 10% since this past week's news that Twitter technology chief Parag Agrawal would replace Dorsey as CEO, Bill Alpert writes in this week's edition of Barron's. The selloff gives investors a buying opportunity they haven't seen in years, the author notes. Reference Link

ShowHide Related Items >><<
TWTR Twitter
$42.07 /

-0.54 (-1.27%)

TWTR Twitter
$42.07 /

-0.54 (-1.27%)

12/02/21 UBS
Twitter assumed with a Neutral at UBS
12/02/21 Piper Sandler
Twitter price target lowered to $54 from $70 at Piper Sandler
12/01/21 Citi
Twitter price target lowered to $47 from $60 at Citi
11/30/21 Jefferies
Twitter leadership changes 'step in right direction,' says Jefferies
TWTR Twitter
$42.07 /

-0.54 (-1.27%)

TWTR Twitter
$42.07 /

-0.54 (-1.27%)

TWTR Twitter
$42.07 /

-0.54 (-1.27%)

TWTR Twitter
$42.07 /

-0.54 (-1.27%)

Periodicals
UMH Properties could ride the housing shortage higher, Barron's says » 09:25
12/04/21
12/04
09:25
12/04/21
09:25
UMH

UMH Properties

$23.37 /

-0.01 (-0.04%)

Good luck finding a deal…

Good luck finding a deal on a home these days-but there are still some to be had in housing stocks, and hares of UMH Properties, an owner and operator of manufactured-home communities, looks like one of them, Carleton English writes in this week's edition of Barron's. UMH is a real estate investment trust that owns 127 manufactured-home communities in 10 states, primarily in the Northeast and Southeast. It makes money from selling and renting manufactured homes-essentially, factory-built houses-with units selling for roughly twice the local annual income in areas where houses can cost more than seven times a year's pay, the author notes. It's a good time to be in the business of selling affordable homes as the Biden administration has made tackling sky-high housing costs a priority, the publication adds. Reference Link

ShowHide Related Items >><<
UMH UMH Properties
$23.37 /

-0.01 (-0.04%)

UMH UMH Properties
$23.37 /

-0.01 (-0.04%)

08/27/21 Wedbush
UMH Properties initiated with an Outperform at Wedbush
06/15/21 B. Riley
UMH Properties price target raised to $25 from $24 at B. Riley
05/12/21 B. Riley
UMH Properties price target raised to $24 from $21 at B. Riley
03/29/21 Aegis
UMH Properties initiated with a Buy at Aegis
UMH UMH Properties
$23.37 /

-0.01 (-0.04%)

Periodicals
Builder stocks worth a look as housing boom to continue, Barron's says » 09:13
12/04/21
12/04
09:13
12/04/21
09:13
DHR

Danaher

$312.94 /

-3.19 (-1.01%)

, LEN

Lennar

$112.31 /

-0.81 (-0.72%)

, PHM

PulteGroup

$52.08 /

-0.425 (-0.81%)

, TOL

Toll Brothers

$68.25 /

-0.265 (-0.39%)

, CCS

Century Communities

$77.05 /

-0.11 (-0.14%)

, MTH

Meritage Homes

$117.87 /

+0.23 (+0.20%)

Housing is booming but…

Housing is booming but housing bull on Wall Street argue that this is an upturn that could last for a decade, Andrew Bary writes in this week's edition of Barron's. The large home builders - D.R. Horton (DHI), Lennar (LEN), PulteGroup (PHM), and Toll Brothers (TOL) - are well positioned to benefit from the demographic trends, with their stocks trading for an average of just seven times projected 2022 earnings, among the lowest multiples in the stock market, the author notes. Small-cap builders Century Communities (CCS) and Meritage Homes (MTH) are even cheaper, fetching about five times forward earnings, Bary adds. Reference Link

ShowHide Related Items >><<
TOL Toll Brothers
$68.25 /

-0.265 (-0.39%)

PHM PulteGroup
$52.08 /

-0.425 (-0.81%)

MTH Meritage Homes
$117.87 /

+0.23 (+0.20%)

LEN Lennar
$112.31 /

-0.81 (-0.72%)

DHR Danaher
$312.94 /

-3.19 (-1.01%)

CCS Century Communities
$77.05 /

-0.11 (-0.14%)

DHR Danaher
$312.94 /

-3.19 (-1.01%)

11/26/21 Benchmark
Recent deals highlight value in ImmunoPrecise shares, says Benchmark
10/25/21 Argus
Danaher well positioned to benefit from development of new medicines, says Argus
10/22/21 Baird
Danaher price target raised to $340 from $305 at Baird
10/22/21 Citi
Danaher price target raised to $370 from $345 at Citi
LEN Lennar
$112.31 /

-0.81 (-0.72%)

12/01/21
Fly Intel: Top five analyst upgrades
12/01/21 Goldman Sachs
Lennar upgraded to Buy from Neutral at Goldman Sachs
11/08/21 BofA
Lennar reinstated with a Buy at BofA
10/14/21 JPMorgan
Lennar price target lowered to $127 from $143 at JPMorgan
PHM PulteGroup
$52.08 /

-0.425 (-0.81%)

11/19/21 Citi
Citi opens '90-day positive catalyst' on PulteGroup
11/08/21 BofA
PulteGroup reinstated with an Underperform at BofA
11/08/21 BofA
PulteGroup reinstated with an Underperform at BofA
10/27/21 Citi
PulteGroup price target raised to $58 from $56 at Citi
TOL Toll Brothers
$68.25 /

-0.265 (-0.39%)

11/08/21 BofA
Toll Brothers reinstated with a Buy at BofA
11/08/21 BofA
Toll Brothers reinstated with a Buy at BofA
10/14/21 JPMorgan
Toll Brothers price target lowered to $61.50 from $72 at JPMorgan
09/27/21 Citi
Toll Brothers price target lowered to $64 from $70 at Citi
CCS Century Communities
$77.05 /

-0.11 (-0.14%)

10/28/21 B. Riley
Century Communities price target raised to $121 from $102 at B. Riley
10/28/21 Wells Fargo
Century Communities price target raised to $75 from $70 at Wells Fargo
10/14/21 JPMorgan
Century Communities price target lowered to $89 from $104 at JPMorgan
10/12/21 B. Riley
Century Communities price target lowered to $102 from $110 at B. Riley
MTH Meritage Homes
$117.87 /

+0.23 (+0.20%)

10/14/21 JPMorgan
Meritage Homes upgraded to Overweight with $143 target at JPMorgan
10/14/21 JPMorgan
Meritage Homes upgraded to Overweight from Neutral at JPMorgan
08/04/21 Wolfe Research
Meritage Homes upgraded to Outperform from Peer Perform at Wolfe Research
06/30/21 Goldman Sachs
Meritage Homes price target lowered to $110 from $117 at Goldman Sachs
TOL Toll Brothers
$68.25 /

-0.265 (-0.39%)

PHM PulteGroup
$52.08 /

-0.425 (-0.81%)

MTH Meritage Homes
$117.87 /

+0.23 (+0.20%)

LEN Lennar
$112.31 /

-0.81 (-0.72%)

DHR Danaher
$312.94 /

-3.19 (-1.01%)

CCS Century Communities
$77.05 /

-0.11 (-0.14%)

MTH Meritage Homes
$117.87 /

+0.23 (+0.20%)

LEN Lennar
$112.31 /

-0.81 (-0.72%)

TOL Toll Brothers
$68.25 /

-0.265 (-0.39%)

MTH Meritage Homes
$117.87 /

+0.23 (+0.20%)

LEN Lennar
$112.31 /

-0.81 (-0.72%)

DHR Danaher
$312.94 /

-3.19 (-1.01%)

TOL Toll Brothers
$68.25 /

-0.265 (-0.39%)

PHM PulteGroup
$52.08 /

-0.425 (-0.81%)

LEN Lennar
$112.31 /

-0.81 (-0.72%)

DHR Danaher
$312.94 /

-3.19 (-1.01%)

Hot Stocks
FDA approves Merck's KEYTRUDA for adjuvant treatment of stage IIB, IIC melanoma » 18:17
12/03/21
12/03
18:17
12/03/21
18:17
MRK

Merck

$73.32 /

-0.57 (-0.77%)

Merck announced that the…

Merck announced that the U.S. Food and Drug Administration has approved KEYTRUDA, Merck's anti-PD-1 therapy, for the adjuvant treatment of adult and pediatric patients with stage IIB or IIC melanoma following complete resection. Additionally, the FDA expanded the indication for KEYTRUDA as adjuvant treatment for stage III melanoma following complete resection to include pediatric patients. The approval in stage IIB and IIC melanoma is based on data from the first interim analysis of the Phase 3 KEYNOTE-716 trial, in which KEYTRUDA showed a statistically significant improvement in recurrence-free survival (RFS), reducing the risk of disease recurrence or death by 35% compared to placebo. Median RFS was not reached for either group. After a median follow-up of 14.4 months, 11% of patients who received KEYTRUDA had recurrence or died compared to 17% of patients who received placebo. Efficacy in pediatric patients with stage IIB, IIC and III melanoma is supported by extrapolation of efficacy data from adults, given similar biology, pharmacology of drug effect, as well as similar exposure-response for efficacy and safety.

ShowHide Related Items >><<
MRK Merck
$73.32 /

-0.57 (-0.77%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
MRK Merck
$73.32 /

-0.57 (-0.77%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

MRK Merck
$73.32 /

-0.57 (-0.77%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.